In addition to in vitro neuroprotective performance of our compounds, transgenic mice expressing G93A SOD1, a frequently used SOD1-ALS mouse model, were treated orally with ebselen and monitored for their motor activities and survival times. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.